Institutional Fund
Deep Track Capital, LP
Greenwich, CTCIK 18560835 filings on record
Portfolio Value
$4.85B
Q1 2026
Holdings
62
Reported positions
New Buys
16
Opened this quarter
QoQ Change
+10.5%
from $4.38B
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Guardant Health Inc6.4%
- Immunovant Inc5.9%
- Tarsus Pharmaceuticals Inc5.2%
- Vaxcyte Inc5.2%
- Structure Therapeutics Inc4.3%
- Axsome Therapeutics Inc3.8%
- Other69.3%
Portfolio Holdings
62 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Guardant Health Inc | 3.34M | $308.35M | 6.4% | +538.2K | Added |
| 2 | Immunovant Inc | 11.53M | $286.33M | 5.9% | 0 | Held |
| 3 | Tarsus Pharmaceuticals Inc | 3.60M | $252.54M | 5.2% | +596.0K | Added |
| 4 | Vaxcyte Inc | 4.30M | $249.87M | 5.2% | +300.0K | Added |
| 5 | Structure Therapeutics Inc | 4.28M | $206.29M | 4.3% | +168.1K | Added |
| 6 | Axsome Therapeutics Inc | 1.10M | $185.92M | 3.8% | −50.0K | Reduced |
| 7 | Apellis Pharmaceuticals Inc | 4.53M | $182.34M | 3.8% | −3.22M | Reduced |
| 8 | Ocular Therapeutix Inc | 19.69M | $166.74M | 3.4% | +11.62M | Added |
| 9 | Vera Therapeutics Inc | 4.11M | $165.19M | 3.4% | +1.28M | Added |
| 10 | Alumis Inc | 6.77M | $149.20M | 3.1% | +6.77M | New |
52 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio